Impacting the Medical Device Value Chain: What is the Right Supply Chain for Your Product?

Companies around the globe are working to develop a set of technologies that will meet the goals of the triple aim – impacting cost, quality, outcomes, and improved population health.  In his book, “The Creative Destruction of Medicine,” Eric Topol, M.D., (the 2017 McKenna lecturer at Arizona State University) identifies a disruptive change in medicine occurring due to an unprecedented “super convergence” of critical elements: low-power wireless biosensors, digital imaging, genome sequencing, mobile connectivity, smartphones, the internet, social networking, virtually unlimited computing power/data storage/bandwidth and pervasive health information systems. The 2017 symposium will focus on innovation in the health sector and impacts on the value chain and supply chains in medical device and pharmaceutical industries.

We will consider ways innovative companies approach product development as well as principal upstream and downstream strategies and risks associated with innovative medical products. The extent to which products and processes are truly disruptive will be considered. Product diversity will be addressed including impacts of evolving business-to-business and business-to-customer strategies, biosensors, 3-D printing, and the shift of care outside of the acute care setting.

To register for the symposium that follows lunch, please visit:

https://www.eventbrite.com/e/2017-symposium-in-innovating-in-the-health-sector-registration-29417290909

Sponsored by the Health Sector Supply Chain Research Consortium